# Lorenza Rimassa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lorenza-rimassa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,614 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 70 |
| i10-index | 249 |
| Last Known Institution | Humanitas University |
| OpenAlex ID | https://openalex.org/A5065803904 |
| ORCID iD | https://orcid.org/0000-0001-9957-3615 |
| Works | 762 |

## Researcher papers

- [NASH limits anti-tumour surveillance in immunotherapy-treated HCC](https://scholariq.org/papers/nash-limits-anti-tumour-surveillance-in-immunotherapy-treated-hcc/)
- [Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up](https://scholariq.org/papers/biliary-tract-cancer-esmo-clinical-practice-guideline-for-diagnosis-treatment/)
- [Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma](https://scholariq.org/papers/four-year-overall-survival-update-from-the-phase-iii-himalaya-study-of/)
- [Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial](https://scholariq.org/papers/safety-and-efficacy-of-preoperative-or-postoperative-chemotherapy-for-resectable/)
- [Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma](https://scholariq.org/papers/management-of-adverse-events-associated-with-tyrosine-kinase-inhibitors/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Humanitas University](https://scholariq.org/institutions/humanitas-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.